| 000 | 01474 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513232739.0 | ||
| 264 | 0 | _c20010719 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0085-2538 | ||
| 024 | 7 |
_a10.1046/j.1523-1755.2001.0590031037.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrice, D A | |
| 245 | 0 | 0 |
_aRenal perfusion and function in healthy African Americans. _h[electronic resource] |
| 260 |
_bKidney international _cMar 2001 |
||
| 300 |
_a1037-43 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBlack or African American |
| 650 | 0 | 4 |
_aAngiotensin II _xpharmacology |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aBlack People |
| 650 | 0 | 4 |
_aCaptopril _xpharmacology |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xphysiology |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aRenal Circulation _xdrug effects |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 650 | 0 | 4 | _aWhite People |
| 700 | 1 | _aFisher, N D | |
| 700 | 1 | _aOsei, S Y | |
| 700 | 1 | _aLansang, M C | |
| 700 | 1 | _aHollenberg, N K | |
| 773 | 0 |
_tKidney international _gvol. 59 _gno. 3 _gp. 1037-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1523-1755.2001.0590031037.x _zAvailable from publisher's website |
| 999 |
_c11168838 _d11168838 |
||